Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Monica Lövestam Adrian
Twelve Per Cent of 6142 Eyes Treated for Neovascular Age‐related Macular Degeneration (nAMD) Presented With Low Visual Outcome Within 2 Years. Analysis From the Swedish Macula Registry (SMR)
Acta Ophthalmologica
Medicine
Ophthalmology
Related publications
Treatment for Neovascular Age-Related Macular Degeneration in Sweden: Outcomes at Seven Years in the Swedish Macula Register
Acta Ophthalmologica
Medicine
Ophthalmology
Aflibercept Improves Outcome in Eyes With Poor Vision From Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Functional and Anatomical Outcome of Eyes With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab Following an Exit Strategy Regimen
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Aflibercept for Neovascular Age-Related Macular Degeneration
Cochrane Database of Systematic Reviews
Characteristics of Eyes With Secondary Loss of Visual Acuity Receiving Variable Dosing Ranibizumab for Neovascular Age-Related Macular Degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Macular Atrophy in Neovascular Age Related Macular Degeneration
Journal of Clinical Review & Case Reports
Assessing the Accuracy of a Large Observational Registry of Neovascular Age-Related Macular Degeneration
Retina
Medicine
Ophthalmology
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration in Patients Aged 90 Years or Older: 2-Year Visual Acuity Outcomes
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
